Coronary event rates in liver transplant recipients reflect the increased prevalence of cardiovascular risk-factors
- 1 August 2005
- journal article
- Published by Frontiers Media SA in Transplant International
- Vol. 18 (8), 967-974
- https://doi.org/10.1111/j.1432-2277.2005.00174.x
Abstract
Increased prevalence of cardiovascular risk-factors in liver transplant recipients compared with pretransplant and standard population data has been acknowledged. The impact of risk-profiles on cardiovascular event rates or death, however, has not yet been established. Here we evaluate the development of risk-factors during a prospective follow-up of 10 years in 302 patients and compare numbers of coronary events with data from the German Prospective Cardiovascular Münster (PROCAM)-Score population. Prevalence of overweight (17% vs. 27%), hypertension (70% vs. 80%), and diabetes (21% vs. 25%) increased from early to late after transplantation, while elevated serum cholesterol (64% vs. 37%) and triglycerides (40% vs. 21%) became less frequent. Cardiovascular risk-profiles favoring tacrolimus over ciclosporin A based immunosuppression early after transplantation converged over time. Increased risk-scores in liver transplant recipients matched with score standardized event rates in the PROCAM population (ratio: 1.11, 95% CI: 0.53-2.03), nine events were predicted for the transplant population and oppose 10 events observed. Thus, indicating a reflection of increased cardiovascular risk-profiles in corresponding numbers of cardiovascular events.Keywords
This publication has 27 references indexed in Scilit:
- Cardiovascular risk factors in 116 patients 5 years or more after liver transplantationTransplant International, 2002
- Long-term management of the liver transplant patient: Diabetes, hyperlipidemia, and obesityLiver Transplantation, 2001
- Beneficial effects of converting liver transplant recipients from cyclosporine to tacrolimus on blood pressure, serum lipids, and weightLiver Transplantation, 2001
- Liver transplantation in cirrhotic patients with diabetes mellitus: Midterm results, survival, and adverse eventsLiver Transplantation, 2001
- Liver transplantation and diabetes mellitusExperimental and Clinical Endocrinology & Diabetes, 2000
- Posttransplantation Hypertension Related to Calcineurin InhibitorsLiver Transplantation, 2000
- Contribution of reduced insulin sensitivity and secretion to the pathogenesis of hepatogenous diabetes: Effect of liver transplantationHepatology, 2000
- Serum cholesterol changes in long-term survivors of liver transplantation: A comparison between cyclosporine and tacrolimus therapyLiver Transplantation and Surgery, 1999
- TEN YEARS OF LIVER TRANSPLANTATIONTransplantation, 1997
- Evolution of cardiovascular risk after liver transplantation: A comparison of cyclosporine A and tacrolimus (FK506)Liver Transplantation, 1997